Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

LCIG improves quality of life, reduces symptoms of Parkinson's

A recent clinical trial conducted at Evergreen Healthcare shows that a new form of a common drug used to treat Parkinson's Disease greatly improves the quality of life for patients and reduces the affects of symptoms such as tremors, slowness, stiffness and difficulty walking.

21 Apr 2012

CTI first quarter net loss decreases 66% to $17.4 million

Cell Therapeutics, Inc. today reported financial results and recent accomplishments for the first quarter of 2012.

21 Apr 2012

First treatment guidelines for NMDA-receptor encephalitis

A mysterious, difficult-to-diagnose, and potentially deadly disease that was only recently discovered can be controlled most effectively if treatment is started within the first month that symptoms occur, according to a new report by researchers from the Perelman School of Medicine at the University of Pennsylvania.

21 Apr 2012

TPU, Eisai amend Aricept patch licensing agreement

Eisai announced today that the company has amended the licensing agreement with Teikoku Pharma USA, Inc. (TPU), a subsidiary of Teikoku Seiyaku Co., Ltd., pertaining to exclusive overseas marketing rights for the Aricept patch (once weekly donepezil HCl transdermal system).

21 Apr 2012

Results from Boehringer Ingelheim's afatinib Phase III lung cancer trial

Highly anticipated results from LUX-Lung 3, the pivotal Phase III lung cancer trial investigating Boehringer Ingelheim's front running oncology investigational compound, the ErbB Family Blocker afatinib, in patients with EGFR mutations, will be presented at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago from 1 - 5 June 2012.

21 Apr 2012

GE Healthcare, NXT2B partner to develop micro-scale radiotracer infrastructure

GE Healthcare, a unit of General Electric Company, and NXT2B, a privately owned venture capital company, today announced they have entered into a joint financing agreement with the goal of developing a micro-scale radiotracer infrastructure including cyclotron and PET tracer production.

20 Apr 2012

K. Hovnanian Children's Hospital announces opening of new specialty care center

K. Hovnanian Children's Hospital at Jersey Shore University Medical Center is proud to announce the grand opening of K. Hovnanian Children's Hospital Specialty Care Center, a consolidated outpatient pediatric center serving as the new home of Meridian Pediatric Associates. The center provides pediatric specialty care services in a comfortable and friendly environment, and is an important first step of the hospital's new pediatric expansion project.

20 Apr 2012

Study shows efficacy of Infant Behavior, Cry and Sleep Clinic's model of integrated care

Having a new baby brings much joy to a new family. But for a family whose baby cries for hours on end, fusses through feedings, or has difficulty sleeping, the joy may be overshadowed by feelings of helplessness and frustration. The treatment of that infant - and that family - will impact the parent-child relationship for years to come.

20 Apr 2012

JSUMC launches Soiree at the Shore event

This year the Jersey Shore University Medical Center Foundation is proud to announce the launch of Soiree at the Shore, a new and exciting event taking the calendar date of the successful Runway on the River.

20 Apr 2012

HIAE, MD Anderson partner to develop oncology program

The University of Texas MD Anderson Cancer Center today announced an agreement with Hospital Israelita Albert Einstein (HIAE) in São Paulo, Brazil, creating an alliance to develop a comprehensive, multidisciplinary oncology program at the hospital.

20 Apr 2012

Study evaluates factors associated with breast cancer worry

"Cancer worry" is the fear that cancer will return, said researchers at Moffitt Cancer Center who studied cancer worry among breast cancer survivors and published their findings in Psycho-Oncology. They found that even three years after successful treatment, two-thirds of the 202 breast cancer survivors who participated in their study said they had "a moderate level of worry."

20 Apr 2012

Palatin, AstraZeneca initiate second AZD2820 phase I trial in obesity

Palatin Technologies, Inc. today announced that a second phase I clinical trial of AZD2820, a subcutaneously-administered peptide melanocortin receptor partial agonist under development for the treatment of obesity, has commenced.

20 Apr 2012

Breast cancer treatment and classification revolutionized in landmark study

Breast cancer treatment could be revolutionized with patients offered more accurate diagnoses and better-targeted treatments after a study in which scientists genetically charted the disease. The research found that rather than being a single disease, breast cancer can be classified into 10 distinct types. It also identified several new genes that determine the aggressiveness of the cancer.

19 Apr 2012

Surgeons not including radiation oncologists early enough in treatment decision-making processes

Surgeons are not always including radiation oncologists early enough in a patient's treatment decision-making process, leaving some patients uninformed of all of their treatment options and potentially leading to more mastectomies over breast-conserving therapy, according to a study in the April issue of the International Journal of Radiation Oncology-Biology-Physics, the official scientific journal of the American Society for Radiation Oncology (ASTRO).

19 Apr 2012

Inform Genomics completes first phase in oral mucositis risk prediction study

Inform Genomics, Inc., a private company focused on developing novel platforms of personalized medicine products for cancer supportive care and inflammatory diseases, today announced the completion of the first phase of product development to predict a patient's risk of developing oral mucositis after receiving high dose chemotherapy prior to hematopoietic stem cell transplant.

19 Apr 2012

Developments in mesothelioma treatment presented at 3rd European Lung Cancer Conference

New results presented at 3rd European Lung Cancer Conference in Geneva, Switzerland show important steps being made to improve the diagnosis and treatment of malignant pleural mesothelioma, an aggressive cancer of the outer lining of the lungs caused by asbestos exposure.

19 Apr 2012

NSCLC patients with EGFR mutations benefit from erlotinib-first regimen

Patients with advanced non-small cell lung cancer should only receive treatment with the drug erlotinib before receiving standard chemotherapy if their tumor is known to harbor EGFR mutations, researchers report at the 3rd European Lung Cancer Conference in Geneva, Switzerland.

19 Apr 2012

New studies on personalized lung cancer treatment presented at 3rd ELCC

Several new studies that may help doctors tailor lung cancer treatment to the characteristics of individual patients and of their tumors are being presented at the 3rd European Lung Cancer Conference in Geneva.

19 Apr 2012

New techniques show promise in detecting early-stage lung cancer

New techniques for identifying lung cancer earlier -including a new type of chest screening, a nanotech 'nose' and a method to examine the cells of the cheek-- are showing substantial promise, according to presentations at the 3rd European Lung Cancer Conference (ELCC) in Geneva.

19 Apr 2012

ESTRO 31 and the World Congress of Brachytherapy to take place from May 9-13

ESTRO 31 and the World Congress of Brachytherapy will combine to feature new research results in clinical and basic radiobiology, physics and brachytherapy, presented by top doctors and scientists from all over the world working together for the benefit of cancer patients.

19 Apr 2012